Pathstone Holdings
TWST icon

Pathstone Holdings’s Twist Bioscience TWST Stock Holding History

Pathstone Holdings’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,362
Closed -$249K – 2386
2024
Q4 		$249K Buy
5,362
+893
+20% +$40.4K ﹤0.01% 2055
2024
Q3 		$202K Sell
4,469
-1,383
-24% -$65.8K ﹤0.01% 2168
2024
Q2 		$288K Sell
5,852
-270
-4% -$11K ﹤0.01% 1960
2024
Q1 		$210K Buy
+6,122
New +$221K ﹤0.01% 2119

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Pathstone Holdings's TWST Position: Q1 2025 in Review

Pathstone Holdings sold out of Twist Bioscience (TWST) in Q1 2025, closing a stake of 5,362 shares — an estimated $249K sold.

Pathstone Holdings first reported a position in TWST in Q1 2024 and held it in 4 quarters. The position peaked at $288K in Q2 2024. 262 funds tracked by Wall St. Rank hold TWST as of Q1 2025.

  • Pathstone Holdings reported no remaining Twist Bioscience position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 5,362 Twist Bioscience shares in Q1 2025, an estimated $249K.
  • Pathstone Holdings first reported a position in Twist Bioscience in Q1 2024 and held it in 4 quarters.
  • Pathstone Holdings's Twist Bioscience position peaked at $288K in Q2 2024.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.